Smart Holograms, a Cambridge-based business commercializing sensor hologram technologies for new life sciences applications, has raised major first-round funding from a syndicate of UK and international venture capital firms. The investor group includes Partnerships UK and Circus Capital, who have committed €4.5 million with an option to invest an additional €3 million.Smart Holograms is exploiting a technology that uses chemically engineered holograms to detect the presence of specific human disease analytes. The holograms require little or no instrumentation and will change their color when in contact with the target indicator. The technology is also protected by 17 international patents. The startup company was spun out of the laboratories of Professor Chris Lowe of the University of Cambridge in 2002.
If you like to be updated on investment deals done in Europe, subscribe now to our Weekly Deals in Europe Report
Related stories
